Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bionik Laboratories Corp. (BNKL : OTC)

• Company Description    Bionik Laboratories Corp. is a medical device and robotics company which focuses in developing transformational technologies and solutions for individuals with neurological disorders. The company offers ARKE, a lower body exoskeleton for wheelchair bound individuals suffering from spinal cord injuries, strokes and other mobility disabilities to restore gait and walk again during the rehabilitation process. It also provides Cronos and the Apollo research programs. Chronos system is a patient queuing system for clinics and hospitals; Apollo is an above-the-knee prosthetic device. Bionik Laboratories Corp. is headquartered in Toronto, Canada. Number of Employees: 18

• Price / Volume Information    Yesterday's Closing Price: $0.50 Daily Weekly Monthly 20 Day Moving Average: 50 shares Shares Outstanding: 5.79 (millions) Market Capitalization: $2.90 (millions) Beta: -0.64 52 Week High: $2.86 52 Week Low: $0.38 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 33.33% 50.16% 12 Week -44.44% -38.93% Year To Date -37.50% -23.63%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 80 COOLIDGE HILL ROAD - WATERTOWN,MA 02472 USA ph: 617-926-4800 fax: - rrusso@bioniklabs.com http://www.bioniklabs.com

• General Corporate Information    Officers Andre Auberton - Chairman Eric Dusseux - Chief Executive Officer Rich Russo - Chief Financial Officer Michal Prywata - Director Remi Gaston Dreyfus - Director Peer Information Bionik Laboratories Corp. (ABMD) Bionik Laboratories Corp. (DMDS) Bionik Laboratories Corp. (CPWY.) Bionik Laboratories Corp. (EQUR) Bionik Laboratories Corp. (ECIA) Bionik Laboratories Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 09074A208 SIC: 3842 Fiscal Year Fiscal Year End: March Last Reported Quarter: 12/01/21 Next Expected EPS Date: 06/23/22 Share - Related Items Shares Outstanding: 5.79 Most Recent Split Date: 10.00 (0.01:1) Beta: -0.64 Market Capitalization: $2.90 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 06/23/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 1.87 EPS Growth vs. Year Ago Period: 23.53% vs. Previous Quarter: -18.18% Sales Growth vs. Year Ago Period: 1.67% vs. Previous Quarter: -19.74% ROE 03/31/22 - - 12/31/21 - -448.07 09/30/21 - -190.99 ROA 03/31/22 - - 12/31/21 - -51.09 09/30/21 - -49.03 Current Ratio 03/31/22 - - 12/31/21 - 0.58 09/30/21 - 0.73 Quick Ratio 03/31/22 - - 12/31/21 - 0.49 09/30/21 - 0.65 Operating Margin 03/31/22 - - 12/31/21 - -296.83 09/30/21 - -309.21 Net Margin 03/31/22 - - 12/31/21 - -630.29 09/30/21 - -759.08 Pre-Tax Margin 03/31/22 - - 12/31/21 - -630.23 09/30/21 - -759.01 Book Value 03/31/22 - - 12/31/21 - -0.75 09/30/21 - 0.41 Inventory Turnover 03/31/22 - - 12/31/21 - 0.52 09/30/21 - 0.48 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - 0.00

Powered by Zacks Investment Research ©